ArticleOncology letters2016

Cisplatin induces HepG2 cell cycle arrest through targeting specific long noncoding RNAs and the p53 signaling pathway.

Ping Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.